<bill session="119" type="s" number="331" updated="2025-10-09T03:26:20Z">
  <state datetime="2025-07-16">ENACTED:SIGNED</state>
  <status>
    <unknown datetime="2025-07-16"/>
  </status>
  <introduced datetime="2025-01-30"/>
  <titles>
    <title type="short" as="introduced">Halt All Lethal Trafficking of Fentanyl Act</title>
    <title type="short" as="introduced">HALT Fentanyl Act</title>
    <title type="short" as="reported to senate">Halt All Lethal Trafficking of Fentanyl Act</title>
    <title type="short" as="reported to senate">HALT Fentanyl Act</title>
    <title type="short" as="passed senate">Halt All Lethal Trafficking of Fentanyl Act</title>
    <title type="short" as="passed senate">HALT Fentanyl Act</title>
    <title type="short">Halt All Lethal Trafficking of Fentanyl Act</title>
    <title type="short">HALT Fentanyl Act</title>
    <title type="display">HALT Fentanyl Act</title>
    <title type="official" as="introduced">A bill to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="C001075"/>
  <cosponsors>
    <cosponsor bioguide_id="B001243" joined="2025-02-03"/>
    <cosponsor bioguide_id="B001319" joined="2025-02-03"/>
    <cosponsor bioguide_id="C001047" joined="2025-01-30"/>
    <cosponsor bioguide_id="C001035" joined="2025-03-06"/>
    <cosponsor bioguide_id="C001056" joined="2025-01-30"/>
    <cosponsor bioguide_id="C001113" joined="2025-01-30"/>
    <cosponsor bioguide_id="C001098" joined="2025-02-03"/>
    <cosponsor bioguide_id="D000618" joined="2025-01-30"/>
    <cosponsor bioguide_id="E000295" joined="2025-03-10"/>
    <cosponsor bioguide_id="G000574" joined="2025-01-30"/>
    <cosponsor bioguide_id="G000359" joined="2025-02-03"/>
    <cosponsor bioguide_id="G000386" joined="2025-01-30"/>
    <cosponsor bioguide_id="H001076" joined="2025-01-30"/>
    <cosponsor bioguide_id="H001089" joined="2025-02-03"/>
    <cosponsor bioguide_id="H001046" joined="2025-01-30"/>
    <cosponsor bioguide_id="H001079" joined="2025-03-11"/>
    <cosponsor bioguide_id="J000312" joined="2025-03-06"/>
    <cosponsor bioguide_id="K000377" joined="2025-01-30"/>
    <cosponsor bioguide_id="K000393" joined="2025-01-30"/>
    <cosponsor bioguide_id="K000383" joined="2025-01-30"/>
    <cosponsor bioguide_id="L000577" joined="2025-02-03"/>
    <cosponsor bioguide_id="M001198" joined="2025-01-30"/>
    <cosponsor bioguide_id="M001243" joined="2025-03-06"/>
    <cosponsor bioguide_id="M001244" joined="2025-02-11"/>
    <cosponsor bioguide_id="R000618" joined="2025-03-06"/>
    <cosponsor bioguide_id="R000605" joined="2025-01-30"/>
    <cosponsor bioguide_id="S001227" joined="2025-01-30"/>
    <cosponsor bioguide_id="S001181" joined="2025-01-30"/>
    <cosponsor bioguide_id="S001198" joined="2025-03-06"/>
    <cosponsor bioguide_id="T000476" joined="2025-02-03"/>
    <cosponsor bioguide_id="Y000064" joined="2025-01-30"/>
  </cosponsors>
  <actions>
    <action datetime="2025-01-30">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2025-01-30" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
    </action>
    <action datetime="2025-02-27" state="REPORTED">
      <text>Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
    </action>
    <action datetime="2025-03-03">
      <text>Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.</text>
    </action>
    <calendar datetime="2025-03-03" calendar="Senate Legislative" under="General Orders" number="18">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 18.</text>
    </calendar>
    <action datetime="2025-03-04">
      <text>Motion to proceed to consideration of measure made in Senate.</text>
      <reference ref="CR S1488"/>
    </action>
    <action datetime="2025-03-04">
      <text>Cloture motion on the motion to proceed to the measure presented in Senate.</text>
      <reference ref="CR S1488"/>
    </action>
    <action datetime="2025-03-05">
      <text>Motion to proceed to measure considered in Senate.</text>
      <reference ref="CR S1521"/>
    </action>
    <action datetime="2025-03-06">
      <text>Motion to proceed to measure considered in Senate.</text>
      <reference ref="CR S1596"/>
    </action>
    <vote-aux how="roll" type="cloture" roll="110" datetime="2025-03-06" where="s" result="pass">
      <text>Cloture on the motion to proceed to the measure invoked in Senate by Yea-Nay Vote. 82 - 12. Record Vote Number: 110.</text>
      <reference ref="CR S1596"/>
    </vote-aux>
    <action datetime="2025-03-10">
      <text>Motion to proceed to measure considered in Senate.</text>
      <reference ref="CR S1623"/>
    </action>
    <action datetime="2025-03-10">
      <text>Motion to proceed to consideration of measure agreed to in Senate by Voice Vote.</text>
      <reference ref="CR S1623" label="consideration"/>
    </action>
    <action datetime="2025-03-10">
      <text>Measure laid before Senate by motion.</text>
    </action>
    <action datetime="2025-03-11">
      <text>Considered by Senate.</text>
      <reference ref="CR S1659" label="consideration"/>
    </action>
    <action datetime="2025-03-11">
      <text>Cloture motion on the measure presented in Senate.</text>
      <reference ref="CR S1659"/>
    </action>
    <action datetime="2025-03-13">
      <text>Cloture on the measure invoked in Senate by Yea-Nay Vote. 84 - 15. Record Vote Number: 124.</text>
      <reference ref="CR S1735"/>
    </action>
    <action datetime="2025-03-13">
      <text>Considered by Senate.</text>
      <reference ref="CR S1735" label="consideration"/>
    </action>
    <action datetime="2025-03-14">
      <text>Considered by Senate.</text>
      <reference ref="CR S1762-1765" label="consideration"/>
    </action>
    <action datetime="2025-03-14">
      <text>The committee substitute agreed to by Unanimous Consent.</text>
    </action>
    <vote how="roll" type="vote" roll="127" datetime="2025-03-14" where="s" result="pass" state="PASS_OVER:SENATE">
      <text>Passed Senate with an amendment by Yea-Nay Vote. 84 - 16. Record Vote Number: 127.</text>
    </vote>
    <action datetime="2025-03-14">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <action datetime="2025-03-18T12:02:39-04:00">
      <text>Received in the House.</text>
    </action>
    <action datetime="2025-03-18T12:03:00-04:00">
      <text>Held at the desk.</text>
    </action>
    <action datetime="2025-06-09T18:43:43-04:00">
      <text>Rules Committee Resolution H. Res. 489 Reported to House. Rule provides for consideration of H.R. 884, H.R. 2056, H.R. 2096 and S. 331. The resolution provides for consideration of H.R. 884, H.R. 2056, H.R. 2096, and S. 331 under a closed rule with one hour of general debate for each bill. The resolution provides for one motion to recommit on H.R. 884, H.R. 2056, and H.R. 2096, and one motion to commit on S. 331.</text>
    </action>
    <action datetime="2025-06-10T14:16:09-04:00">
      <text>Rule H. Res. 489 passed House.</text>
    </action>
    <action datetime="2025-06-11T13:31:58-04:00">
      <text>Considered under the provisions of rule H. Res. 489.</text>
      <reference ref="CR H2625-2633" label="consideration"/>
    </action>
    <action datetime="2025-06-11T13:32:03-04:00">
      <text>Rule provides for consideration of H.R. 884, H.R. 2056, H.R. 2096 and S. 331. The resolution provides for consideration of H.R. 884, H.R. 2056, H.R. 2096, and S. 331 under a closed rule with one hour of general debate for each bill. The resolution provides for one motion to recommit on H.R. 884, H.R. 2056, and H.R. 2096, and one motion to commit on S. 331.</text>
    </action>
    <action datetime="2025-06-11T13:32:23-04:00">
      <text>DEBATE - The House proceeded with one hour of debate on S. 331.</text>
    </action>
    <action datetime="2025-06-11T14:23:01-04:00">
      <text>The previous question was ordered pursuant to the rule.</text>
    </action>
    <action datetime="2025-06-11T14:23:15-04:00">
      <text>POSTPONED PROCEEDINGS - At the conclusion of debate on S. 331, the Chair put the question on passage of the bill and by voice vote, announced that the ayes had prevailed. Mr. Pallone demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced.</text>
    </action>
    <action datetime="2025-06-12T15:02:29-04:00">
      <text>Considered as unfinished business.</text>
      <reference ref="CR H2806" label="consideration"/>
    </action>
    <vote how="roll" type="vote2" roll="166" datetime="2025-06-12T15:36:34-04:00" where="h" result="pass" state="PASSED:BILL">
      <text>On passage Passed by the Yeas and Nays: 321 - 104 (Roll no. 166).</text>
      <reference ref="6/11/2025 CR H2625-2627" label="text"/>
    </vote>
    <action datetime="2025-06-12T15:36:36-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <topresident datetime="2025-07-08">
      <text>Presented to President.</text>
    </topresident>
    <signed datetime="2025-07-16" state="ENACTED:SIGNED">
      <text>Signed by President.</text>
    </signed>
    <enacted number="119-26" type="public" datetime="2025-07-16">
      <text>Became Public Law No: 119-26.</text>
    </enacted>
  </actions>
  <committees>
    <committee code="SSJU" name="Senate Judiciary" subcommittee="" activity="Reported By, Markup By, Referred To"/>
  </committees>
  <relatedbills>
    <bill session="119" type="hr" number="489" relation="procedurally related"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Department of Justice"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Licensing and registrations"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments>
    <amendment number="s1265"/>
    <amendment number="s1264"/>
    <amendment number="s1263"/>
    <amendment number="s1262"/>
    <amendment number="s1261"/>
    <amendment number="s1260"/>
    <amendment number="s1259"/>
    <amendment number="s1258"/>
    <amendment number="s1257"/>
    <amendment number="s1256"/>
    <amendment number="s1255"/>
    <amendment number="s1254"/>
    <amendment number="s1253"/>
    <amendment number="s1252"/>
    <amendment number="s1251"/>
    <amendment number="s1250"/>
    <amendment number="s1249"/>
    <amendment number="s1248"/>
    <amendment number="s1247"/>
    <amendment number="s1246"/>
    <amendment number="s1245"/>
    <amendment number="s1244"/>
    <amendment number="s1243"/>
    <amendment number="s1242"/>
    <amendment number="s1241"/>
    <amendment number="s1240"/>
    <amendment number="s1239"/>
    <amendment number="s1238"/>
    <amendment number="s1237"/>
    <amendment number="s1236"/>
    <amendment number="s1235"/>
    <amendment number="s1234"/>
    <amendment number="s1233"/>
    <amendment number="s1232"/>
    <amendment number="s1231"/>
  </amendments>
  <summary date="2025-03-05T15:36:42Z" status="Introduced in Senate">Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act

This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).

Additionally, the bill establishes a new, alternative registration process for certain schedule I research.

The bill also makes several other changes to registration requirements for conducting research with controlled substances, including

permitting a single registration for related research sites in certain circumstances,waiving the requirement for a new inspection in certain situations, andallowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.Finally, the bill expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.</summary>
</bill>
